Rankings
▼
Calendar
IONS Q4 2016 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IONS
Ionis Pharmaceuticals, Inc.
$12B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$160M
Gross Profit
$59M
36.9% margin
Operating Income
$41M
25.7% margin
Net Income
$26M
16.1% margin
EPS (Diluted)
$0.21
QoQ Revenue Growth
+44.6%
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$30M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$912M
Total Liabilities
$813M
Stockholders' Equity
$100M
Cash & Equivalents
$85M
← FY 2016
All Quarters
Q1 2017 →
